Hakobyan Varduhi, Sargsyan Khachik, Elbakyan Hasmik, Sargsyan Vazgen, Markosyan Tigran, Chobanyan Gayane, Badalyan Manvel, Kharatyan Satenik
Scientific Center for Risk Assessment and Analysis in Food Safety Area, 107/2 Masis Highway, Shengavit, Yerevan 0071, Armenia.
Chair of Biosciences and General Chemistry, Armenian National Agrarian University, 74 Teryan Street, Yerevan 0009, Armenia.
Vet Sci. 2024 Apr 5;11(4):164. doi: 10.3390/vetsci11040164.
The transmission of lumpy skin disease (LSD) occurs through ticks, mosquitoes, and flies. The most effective way to combat LSD is to conduct large-scale vaccination, covering the entire cattle population with safe and effective vaccines, while introducing restrictions on the movement of livestock. The first and only LSD cases that occurred in Armenia happened in 2015,and they were controlled with the use of a once yearly heterologous sheep pox vaccine for cattle in high-risk areas. We have previously reported on the safety and immunogenicity of this vaccine in cattle, but information on the duration of immunity is lacking. Our aim was to determine the duration of immunity to the LSD virus (LSDV) in cattle when utilizing a heterologous sheep pox vaccine. We have evaluated antibodies in cattle blood prior to and post-vaccination (1, 6, and 11 months). We have utilized an enzyme-linked immunosorbent assay to follow the development and waning of LSDV antibodies in vaccinated cattle in two age groups: 1) young unvaccinated cattle ≤12 months of age and 2) adult cattle that had previously been vaccinated. Our results were consistent with our previous study in Armenia, showing a high level of population immunity, 80.0-83.3%, in both age groups at 1 month, with a significant ( = 0.001) drop for young cattle at 6 months. Previously vaccinated adult cattle showed a longer duration of immunity at 11 months for this heterologous sheep pox vaccine. Based on these data, we advise that young cattle receive an additional booster vaccination 4-6 months after their first vaccination, and then yearly vaccinations in high-risk areas.
结节性皮肤病(LSD)通过蜱、蚊子和苍蝇传播。对抗LSD最有效的方法是进行大规模疫苗接种,用安全有效的疫苗覆盖整个牛群,同时对牲畜的流动实施限制。亚美尼亚发生的首例也是唯一的LSD病例发生在2015年,当时在高风险地区使用每年一次的牛用异源羊痘疫苗对其进行了控制。我们之前已报道过这种疫苗在牛身上的安全性和免疫原性,但缺乏关于免疫持续时间的信息。我们的目的是确定使用异源羊痘疫苗时牛对LSD病毒(LSDV)的免疫持续时间。我们评估了接种疫苗前后(1个月、6个月和11个月)牛血液中的抗体。我们利用酶联免疫吸附测定法追踪了两个年龄组接种疫苗的牛体内LSDV抗体的产生和消退情况:1)年龄≤12个月的未接种疫苗的幼牛和2)先前已接种疫苗的成年牛。我们的结果与我们之前在亚美尼亚的研究一致,显示两个年龄组在1个月时群体免疫水平较高,为80.0 - 83.3%,幼牛在6个月时显著下降(P = 0.001)。对于这种异源羊痘疫苗,先前接种过疫苗的成年牛在11个月时显示出更长的免疫持续时间。基于这些数据,我们建议幼牛在首次接种疫苗后4 - 6个月接受额外的加强疫苗接种,然后在高风险地区每年进行疫苗接种。